Medical devices, healthcare technology and the business of care
510(k) clearance · K262193

RIVA Posterior Fixation System with NanoACTIV Surface Technology; RIVA Anchor Sacroiliac Fixation System with NanoACTIV Surface Technology

Xenix Medical · Decision date Sep 14, 2026

MEDTECHLEDGER EXPLANATIONK262193

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-14 for K262193, a traditional 510(k) submitted 06/29/2026 by Xenix Medical of Orlando, Florida. The device is listed as the RIVA® Posterior Fixation System with NanoACTIV Surface Technology and the RIVA® Anchor Sacroiliac Fixation System with NanoACTIV Surface Technology, under device classification Thoracolumbosacral Pedicle Screw System, regulation 888.3070, product code NKB, with subsequent product codes KWQ, OLO and OUR. The orthopedic panel reviewed it; it was not reviewed by a third party, is not a combination product, and no predetermined change control plan was authorized. SESE means clearance, not PMA approval.

The available records do not establish what, if anything, changed relative to a predicate device, nor do they give the full indications, performance data or labeling. One document excerpt references sacroiliac joint fusion for the Anchor system and immobilization and stabilization of spinal segments for the Posterior Fixation System, but the excerpt is truncated and the complete indications remain in the FDA documents. No clinical or comparative conclusions are drawn here.

The public record also does not identify the predicate device, the basis for the equivalence determination, or any conditions of clearance. Readers needing those details should consult the decision letter and the cleared labeling rather than this summary.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 14, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262193
Regulatory pathway
510(k) premarket notification
Applicant
Xenix Medical
Product code
NKB
Decision code
SESE
Decision date
Sep 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Thoracolumbosacral Pedicle Screw System.

Applicant
Xenix Medical
Product code
NKB
FDA device class
2

FDA decision timeline

  1. K262193 received

    Application receipt date recorded by FDA.

  2. K262193 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKB

Product / regulatory recordCompanyPathwayDecision dateSource
SeaSpine Orthopedics Corporation510(k) clearanceOct 29, 2026FDA
GS Medical Co., Ltd.510(k) clearanceOct 2, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 1, 2026FDA
Duet Spine Holdings, LLC510(k) clearanceSep 30, 2026FDA
Spinal Alignment Solutions, Inc.510(k) clearanceSep 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Xenix Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Orlando, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records